Fresenius Medical Care AG & Co. KGaA (FME) - Financial and Strategic SWOT Analysis Review

Date: July 1, 2014
Pages: 50
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: F9B7BDC30CAEN
Leaflet:

Download PDF Leaflet

Fresenius Medical Care AG & Co. KGaA (FME) - Financial and Strategic SWOT Analysis Review
Fresenius Medical Care AG & Co. KGaA (FME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Fresenius Medical Care AG & Co. KGaA (Fresenius Medical) is an integrated dialysis company. It offers a wide range of products and services to individuals with chronic kidney failure. The company provides dialysis treatment at its clinics and also sells its products to other dialysis service providers. It offers services for clinical laboratory testing, therapeutic aphaeresis, inpatient dialysis, and hemoperfusion among others. The company conducts its operations in Europe, Middle East, Africa, the Americas and Asia-Pacific. Fresenius Medical is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG & Co. KGaA Key Recent Developments

Mar 12, 2014: Fresenius Medical Care Announces Management Board Changes
Feb 25, 2014: Fresenius Medical Care reports fourth quarter and full year 2013 results
Nov 05, 2013: Fresenius Medical Care Reports Third Quarter And Nine Months 2013 Results
May 27, 2013: Fresenius Medical Care Announces Publication Of Catalonian HDF Study In Journal of American Society of Nephrology
Apr 30, 2013: Fresenius Medical Care Reports First Quarter 2013 Results And Confirms Guidance For Full Year 2013

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Fresenius Medical Care AG & Co. KGaA - Key Facts
Fresenius Medical Care AG & Co. KGaA - Key Employees
Fresenius Medical Care AG & Co. KGaA - Key Employee Biographies
Fresenius Medical Care AG & Co. KGaA - Major Products and Services
Fresenius Medical Care AG & Co. KGaA - History
Fresenius Medical Care AG & Co. KGaA - Company Statement
Fresenius Medical Care AG & Co. KGaA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Fresenius Medical Care AG & Co. KGaA - Business Description
Business Description - Dialysis Products
Dialysis Products - Overview
Dialysis Products - Financials
Dialysis Products - Technology
Business Description - Dialysis Services
Dialysis Services - Overview
Dialysis Services - Financials
Dialysis Services - Market View
Fresenius Medical Care AG & Co. KGaA - Corporate Strategy
Fresenius Medical Care AG & Co. KGaA - SWOT Analysis
SWOT Analysis - Overview
Fresenius Medical Care AG & Co. KGaA - Strengths
Strength - Well Established Player
Strength - Vertically Integrated Operations
Strength - Worldwide Manufacturing Facilities
Fresenius Medical Care AG & Co. KGaA - Weaknesses
Weakness - Product Recalls
Weakness - Reliance on Referrals
Fresenius Medical Care AG & Co. KGaA - Opportunities
Opportunity - Expanding Peritoneal Dialysis Market
Opportunity - Partnership and Agreements
Opportunity - Strategic Acquisitions
Fresenius Medical Care AG & Co. KGaA - Threats
Threat - Competitive Environment
Threat - FDA Warning Letters
Threat - Rapid Technological Changes
Threat - Stringent Regulations
Fresenius Medical Care AG & Co. KGaA - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Fresenius Medical Care AG & Co. KGaA, Medical Equipment, Deals By Year, 2008 to YTD 2014
Fresenius Medical Care AG & Co. KGaA, Medical Equipment, Deals By Type, 2008 to YTD 2014
Fresenius Medical Care AG & Co. KGaA, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 02, 2014: GranuFlo Lawsuits Now Being Filed by Bernstein Liebhard in Massachusetts Federal Court
Mar 26, 2014: Fresenius Medical Care North America Introduces Frenova Renal Research
Mar 12, 2014: Fresenius Medical Care Announces Management Board Changes
Feb 25, 2014: Fresenius Medical Care reports fourth quarter and full year 2013 results
Nov 05, 2013: Fresenius Medical Care Reports Third Quarter And Nine Months 2013 Results
Jul 02, 2013: Fresenius Wins Federal Circuit Case Against Baxter Over Patent For Hemodialysis Machine
May 27, 2013: Fresenius Medical Care Announces Publication Of Catalonian HDF Study In Journal of American Society of Nephrology
Apr 30, 2013: Fresenius Medical Care Reports First Quarter 2013 Results And Confirms Guidance For Full Year 2013
Mar 14, 2013: Fresenius Medical Care Receives FDA Warning Letter Over Dialyzer Validation Issues At Utah Plant
Feb 26, 2013: Fresenius Medical Reports Revenue Of $13.8 Billion In 2012

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Fresenius Medical Care AG & Co. KGaA, Key Facts
Fresenius Medical Care AG & Co. KGaA, Key Employees
Fresenius Medical Care AG & Co. KGaA, Key Employee Biographies
Fresenius Medical Care AG & Co. KGaA, Major Products and Services
Fresenius Medical Care AG & Co. KGaA, History
Fresenius Medical Care AG & Co. KGaA, Other Locations
Fresenius Medical Care AG & Co. KGaA, Subsidiaries
Fresenius Medical Care AG & Co. KGaA, Key Competitors
Fresenius Medical Care AG & Co. KGaA, Ratios based on current share price
Fresenius Medical Care AG & Co. KGaA, Annual Ratios
Fresenius Medical Care AG & Co. KGaA, Interim Ratios
Fresenius Medical Care AG & Co. KGaA, Medical Equipment, Deals By Year, 2008 to YTD 2014
Fresenius Medical Care AG & Co. KGaA, Medical Equipment, Deals By Type, 2008 to YTD 2014
Fresenius Medical Care AG & Co. KGaA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Fresenius Medical Care AG & Co. KGaA, Performance Chart (2009 - 2013)
Fresenius Medical Care AG & Co. KGaA, Ratio Charts
Fresenius Medical Care AG & Co. KGaA, Medical Equipment, Deals By Year, 2008 to YTD 2014
Fresenius Medical Care AG & Co. KGaA, Medical Equipment, Deals by Type, 2008 to YTD 2014
Skip to top


Ask Your Question

Fresenius Medical Care AG & Co. KGaA (FME) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: